Graphical abstract. Credit: Journal of Controlled Release (2024). DOI: 10.1016/j.jconrel.2023.12.043 Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the...
Some are saying that mRNA medicines—mRNA vaccines and mRNA therapeutics alike—will open a golden era of medicine. And the enthusiasm is catching. Following the precedent set by the first mRNA-based COVID-19 vaccines, hundreds of new mRNA medicines are moving through...
ACDN-01 is the first RNA exon editor to enter clinical development and the only clinical-stage therapeutic targeting the genetic cause of Stargardt disease Ascidian expects to initiate enrollment in Phase 1/2 STELLAR study in the first half of 2024 ACDN-01 also...
Credit: Cell Reports (2024). DOI: 10.1016/j.celrep.2023.113644 Breast cancer is the most common cancer in women. The development of breast cancer often originates from epithelial cells in the mammary gland—the very cells that specialize in milk production during and...
RNA could be considered DNA’s younger sibling. From the very beginning, RNA’s milestones came later and attracted less attention than DNA’s milestones. For example, the discovery of DNA’s structure was first published in 1953; the corresponding discovery for RNA’s...
